These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28734784)

  • 1. Drug Delivery Innovations to Address Global Health Challenges for Pediatric and Geriatric Populations (Through Improvements in Patient Compliance).
    Boateng J
    J Pharm Sci; 2017 Nov; 106(11):3188-3198. PubMed ID: 28734784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.
    Sosnik A; Seremeta KP; Imperiale JC; Chiappetta DA
    Expert Opin Drug Deliv; 2012 Mar; 9(3):303-23. PubMed ID: 22257003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric and geriatric drug delivery.
    Breitkreutz J; Boos J
    Expert Opin Drug Deliv; 2007 Jan; 4(1):37-45. PubMed ID: 17184161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Drug Delivery Systems.
    Jain KK
    Methods Mol Biol; 2020; 2059():1-54. PubMed ID: 31435914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to improve the use of antimalarials in south-east Asia: an overview.
    Gomes M; Wayling S; Pang L
    Bull World Health Organ; 1998; 76 Suppl 1(Suppl 1):9-19. PubMed ID: 9763718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient centric formulations for paediatrics and geriatrics: Similarities and differences.
    Hanning SM; Lopez FL; Wong IC; Ernest TB; Tuleu C; Orlu Gul M
    Int J Pharm; 2016 Oct; 512(2):355-359. PubMed ID: 26976504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage form modification and oral drug delivery in older people.
    Lau ETL; Steadman KJ; Cichero JAY; Nissen LM
    Adv Drug Deliv Rev; 2018 Oct; 135():75-84. PubMed ID: 29660383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug administration and dosage forms in geriatric patients].
    Heppner HJ; Sieber CC; Esslinger AS; Trögner J
    Ther Umsch; 2006 Jun; 63(6):419-22. PubMed ID: 16841579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and innovations of delivering medicines to older adults.
    Gnjidic D; Husband A; Todd A
    Adv Drug Deliv Rev; 2018 Oct; 135():97-105. PubMed ID: 30118723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public engagement workshop: how to improve medicines for older people?
    Orlu-Gul M; Raimi-Abraham B; Jamieson E; Wei L; Murray M; Stawarz K; Stegemann S; Tuleu C; Smith FJ
    Int J Pharm; 2014 Jan; 459(1-2):65-9. PubMed ID: 24291080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-malarial drug formulations and novel delivery systems: a review.
    Murambiwa P; Masola B; Govender T; Mukaratirwa S; Musabayane CT
    Acta Trop; 2011 May; 118(2):71-9. PubMed ID: 21439929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges.
    Wen H; Jung H; Li X
    AAPS J; 2015 Nov; 17(6):1327-40. PubMed ID: 26276218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory incentives to ensure better medicines for older people: From ICH E7 to the EMA reflection paper on quality aspects.
    van Riet-Nales DA; Hussain N; Sundberg KA; Eggenschwyler D; Ferris C; Robert JL; Cerreta F
    Int J Pharm; 2016 Oct; 512(2):343-351. PubMed ID: 27150947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals.
    Bellinger AM; Jafari M; Grant TM; Zhang S; Slater HC; Wenger EA; Mo S; Lee YL; Mazdiyasni H; Kogan L; Barman R; Cleveland C; Booth L; Bensel T; Minahan D; Hurowitz HM; Tai T; Daily J; Nikolic B; Wood L; Eckhoff PA; Langer R; Traverso G
    Sci Transl Med; 2016 Nov; 8(365):365ra157. PubMed ID: 27856796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Immediate Release to Long Acting Drug Delivery Systems: What Do They Mean and Why Do They Matter?
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 May; 55(5):19-23. PubMed ID: 28460145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.